A detailed history of Innova Wealth Partners transactions in Abb Vie Inc. stock. As of the latest transaction made, Innova Wealth Partners holds 1,506 shares of ABBV stock, worth $271,080. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,506
Previous 4,721 68.1%
Holding current value
$271,080
Previous $809,000 63.29%
% of portfolio
0.27%
Previous 0.62%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$163.84 - $199.33 $526,745 - $640,845
-3,215 Reduced 68.1%
1,506 $297,000
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $12,537 - $14,641
81 Added 1.75%
4,721 $809,000
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $3,356 - $3,824
21 Added 0.45%
4,640 $844,000
Q4 2023

Feb 07, 2024

BUY
$137.6 - $154.97 $10,457 - $11,777
76 Added 1.67%
4,619 $715,000
Q3 2023

Oct 23, 2023

BUY
$133.59 - $154.65 $62,920 - $72,840
471 Added 11.57%
4,543 $677,000
Q2 2023

Jul 13, 2023

SELL
$132.51 - $164.9 $32,994 - $41,060
-249 Reduced 5.76%
4,072 $548,000
Q4 2022

Jan 17, 2023

BUY
$138.31 - $165.87 $7,053 - $8,459
51 Added 1.19%
4,321 $0
Q3 2022

Oct 18, 2022

SELL
$134.21 - $153.93 $13,286 - $15,239
-99 Reduced 2.27%
4,270 $573,000
Q2 2022

Jul 11, 2022

BUY
$137.62 - $174.96 $22,156 - $28,168
161 Added 3.83%
4,369 $669,000
Q1 2022

Apr 18, 2022

SELL
$131.98 - $163.75 $3,827 - $4,748
-29 Reduced 0.68%
4,208 $682,000
Q3 2021

Oct 28, 2021

SELL
$106.4 - $120.78 $6,277 - $7,126
-59 Reduced 1.37%
4,237 $457,000
Q2 2021

Oct 28, 2021

SELL
$105.21 - $117.21 $46,187 - $51,455
-439 Reduced 9.27%
4,296 $484,000
Q1 2021

Oct 28, 2021

BUY
$102.3 - $112.62 $4,194 - $4,617
41 Added 0.87%
4,735 $512,000
Q4 2020

Oct 28, 2021

BUY
$80.49 - $108.67 $377,820 - $510,096
4,694 New
4,694 $503,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Innova Wealth Partners Portfolio

Follow Innova Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Innova Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Innova Wealth Partners with notifications on news.